Bioactives of Momordica charantia as Potential Anti-Diabetic/Hypoglycemic Agents

Molecules. 2022 Mar 28;27(7):2175. doi: 10.3390/molecules27072175.

Abstract

Momordica charantia L., a member of the Curcubitaceae family, has traditionally been used as herbal medicine and as a vegetable. Functional ingredients of M. charantia play important roles in body health and human nutrition, which can be used directly or indirectly in treating or preventing hyperglycemia-related chronic diseases in humans. The hypoglycemic effects of M. charantia have been known for years. In this paper, the research progress of M. charantia phytobioactives and their hypoglycemic effects and related mechanisms, especially relating to diabetes mellitus, has been reviewed. Moreover, the clinical application of M. charantia in treating diabetes mellitus is also discussed, hoping to broaden the application of M. charantia as functional food.

Keywords: Momordica charantia; bioactives; diabetes mellitus; hypoglycemic activity; synergistic effect.

Publication types

  • Review

MeSH terms

  • Diabetes Mellitus, Type 2* / drug therapy
  • Humans
  • Hypoglycemic Agents / pharmacology
  • Hypoglycemic Agents / therapeutic use
  • Momordica charantia*
  • Phytotherapy
  • Plant Extracts / pharmacology
  • Plant Extracts / therapeutic use

Substances

  • Hypoglycemic Agents
  • Plant Extracts